Significant Ownership of Trails Edge Capital Partners, LP

Signature - Title
/s/ Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai - Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Location
Atlanta, GA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Trails Edge Capital Partners, LP.

Notify me when Trails Edge Capital Partners, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Trails Edge Capital Partners, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MIST Milestone Pharmaceuticals Inc. Common Shares 9.9% $18,035,760 +$339,996 9,017,880 +1.9% Trails Edge Capital Partners, LP 30 Sep 2025
PMN ProMIS Neurosciences Inc. Common Shares, no par value per share 9.9% $6,347,644 933,477 Trails Edge Capital Partners, LP 03 Feb 2026
VTVT vTv Therapeutics Inc. Common Stock, par value $0.01 per share 9.9% $5,108,040 340,536 Trails Edge Capital Partners, LP 29 Aug 2025
SNSE Sensei Biotherapeutics, Inc. Common Shares, no par value per share 9.9% $1,217,257 126,010 Trails Edge Capital Partners, LP 18 Feb 2026
IMUX Immunic, Inc. Common Shares, no par value per share 8.7% $6,986,940 11,454,000 Trails Edge Capital Partners, LP 17 Feb 2026
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5.8% $20,333,894 +$11,320,168 5,227,222 +126% Trails Edge Capital Partners, LP 31 Dec 2025
NGNE Neurogene Inc. Common Stock 5.1% $20,794,650 785,000 Trails Edge Capital Partners, LP 08 Dec 2025
IKT Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value 5.1% $9,525,057 6,145,198 Trails Edge Capital Partners, LP 23 Dec 2025
LBRX LB Pharmaceuticals Inc Common Stock, par value $0.0001 5% $20,964,420 1,268,265 Trails Edge Capital Partners, LP 24 Dec 2025

Schedules 13D/G Reported by Trails Edge Capital Partners, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.